NFKB1 and hepatocellular carcinoma: However, inhibition of NFκB activation by anti-TNF treatment or induction of a (transgenic) non-degradable form of IκB at late stages of tumour development in Mdr2−/− mice resulted in apoptosis of transformed hepatocytes and lack of progression to HCC [125].